ReviewArchives of toxicology2026
Research progress on the toxicological characteristics and biodegradation of deoxynivalenol and its derivatives.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Deoxynivalenol (DON) and its derivatives are widely distributed contaminants that seriously threaten food security and animal husbandry production. Biodegradation has become a core research direction for detoxification owing to its high efficiency and specificity. Although numerous studies have reported the toxicity, metabolism and degradation of DON and its derivatives, systematic reviews that integrate toxic mechanisms, species differences, degrading strains and key enzymes remain scarce. This paper comprehensively reviews the toxicological mechanisms and toxicokinetic characteristics of DON and its typical derivatives, and illustrates the physiological basis for species sensitivity differences. It mainly summarizes various degrading bacteria, fungi and core enzymatic catalytic pathways, and analyzes the potential risks of masked mycotoxins as well as the application bottlenecks of current biological detoxification technologies. Future research directions are also prospected. This review can serve as a reference for the research, development and industrial application of efficient and safe microbial detoxification strategies.
Indexed as
Identifiers
42631752What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.